What do we know about the variability in survival of patients with amyotrophic lateral sclerosis?

McCombe, Pamela A; Garton, Fleur C; Katz, Matthew; Wray, Naomi R; Henderson, Robert D

McCombe, Pamela A; Garton, Fleur C; Katz, Matthew; Wray, Naomi R; Henderson, Robert D.

Afiliação

McCombe PA; Centre for Clinical Research, The University of Queensland , Brisbane, Australia.
Garton FC; Department of Neurology, Royal Brisbane and Women's Hospital , Brisbane, Australia.
Katz M; Institute for Molecular Biosciences, The University of Queensland , Brisbane, Australia.
Wray NR; Department of Neurology, Royal Brisbane and Women's Hospital , Brisbane, Australia.
Henderson RD; Institute for Molecular Biosciences, The University of Queensland , Brisbane, Australia.

Expert Rev Neurother ; 20(9): 921-941, 2020 09.

Article em En | MEDLINE | ID: mdl-32569484

Assuntos

Esclerose Lateral Amiotrófica/mortalidade; Humanos

Palavras-chave

Amyotrophic lateral sclerosis; epidemiology; genetics; immune system; metabolism; natural history; neurodegeneration; survival

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Lateral Amiotrófica Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Expert Rev Neurother Assunto da revista: NEUROLOGIA / TERAPEUTICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google